David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$667M |
| 2 |
NVIDIA
NVDA
|
+$584M |
| 3 |
ConocoPhillips
COP
|
+$432M |
| 4 |
Amazon
AMZN
|
+$418M |
| 5 |
Johnson & Johnson
JNJ
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$836M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
Apple
AAPL
|
+$453M |
| 4 |
CELG
Celgene Corp
CELG
|
+$349M |
| 5 |
Pfizer
PFE
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.27% |
| 2 | Consumer Discretionary | 13.7% |
| 3 | Healthcare | 13.3% |
| 4 | Industrials | 7.34% |
| 5 | Financials | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACGN
3101
DELISTED
Aceragen Inc
ACGN
| $424K | ﹤0.01% |
9,346
+3,587
| +62% | +$170K |
|
3102
Kforce
KFRC
$1.03B
| $423K | ﹤0.01% |
+12,041
| New | +$433K |
|
3103
Omega Healthcare
OHI
$14.1B
| $423K | ﹤0.01% |
11,500
-13,471
| -54% | -$491K |
|
|
TRK
3104
DELISTED
Speedway Motorsports, Inc.
TRK
| $422K | ﹤0.01% |
22,763
+884
| +4% | +$15.3K |
|
3105
Ameren
AEE
$29.7B
| $421K | ﹤0.01% |
5,600
+369
| +7% | +$27.2K |
|
3106
Resources Connection
RGP
$147M
| $421K | ﹤0.01% |
26,308
+4,656
| +22% | +$74.2K |
|
3107
SouthState Bank Corp
SSB
$10.4B
| $421K | ﹤0.01% |
5,710
+1,256
| +28% | +$90.3K |
|
|
CHK
3108
DELISTED
Chesapeake Energy Corporation
CHK
| $419K | ﹤0.01% |
1,073
+564
| +111% | +$282K |
|
3109
PUT
Kinder Morgan
KMI
$69B
| $418K | ﹤0.01% |
20,000
| – | – |
|
3110
Interactive Brokers
IBKR
$42.2B
| $416K | ﹤0.01% |
+30,356
| New | +$412K |
|
3111
PUT
Boston Beer
SAM
$1.95B
| $416K | ﹤0.01% |
+1,100
| New | +$348K |
|
3112
PUT
FMC
FMC
$1.41B
| $415K | ﹤0.01% |
5,000
| – | – |
|
3113
PUT
Matador Resources
MTDR
$7.12B
| $415K | ﹤0.01% |
20,900
-8,200
| -28% | -$156K |
|
3114
German American Bancorp
GABC
$1.88B
| $414K | ﹤0.01% |
13,731
+5,241
| +62% | +$154K |
|
|
LKFT
3115
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.9B
| $414K | ﹤0.01% |
3,208
-19,691
| -86% | -$2.34M |
|
|
HIMX
3116
Himax Technologies
HIMX
$2.34B
| $414K | ﹤0.01% |
+118,961
| New | +$393K |
|
|
SFE
3117
DELISTED
Safeguard Scientifics, Inc.
SFE
| $414K | ﹤0.01% |
34,323
-8,576
| -20% | -$100K |
|
3118
Community Trust Bancorp
CTBI
$1.39B
| $413K | ﹤0.01% |
9,772
+1,646
| +20% | +$68.3K |
|
3119
Quad
QUAD
$528M
| $413K | ﹤0.01% |
52,248
-40,172
| -43% | -$420K |
|
3120
Ryman Hospitality Properties
RHP
$9.05B
| $412K | ﹤0.01% |
5,083
-800
| -14% | -$65.5K |
|
|
CRZO
3121
CALL
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $412K | ﹤0.01% |
41,100
+1,800
| +5% | +$20.7K |
|
3122
Lexicon Pharmaceuticals
LXRX
$1.03B
| $411K | ﹤0.01% |
65,437
-170,684
| -72% | -$1.02M |
|
3123
Rollins
ROL
$17.9B
| $411K | ﹤0.01% |
+17,177
| New | +$443K |
|
|
CHK
3124
CALL
DELISTED
Chesapeake Energy Corporation
CHK
| $410K | ﹤0.01% |
1,050
| – | – |
|
|
PVLA
3125
Palvella Therapeutics
PVLA
$2.1B
| $407K | ﹤0.01% |
1,082
+165
| +18% | +$49.2K |
|
Similar funds
David Shaw's Q2 2019 Portfolio in Review
As of Q2 2019, David Shaw held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
- David Shaw added most to Alibaba in Q2 2019, an estimated $667M increase.
- David Shaw's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
- David Shaw's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
- David Shaw opened 499 new positions and closed 416 in Q2 2019.
- David Shaw's portfolio value rose 3.6% quarter-over-quarter to $80.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.